MarketCap
Facebook
X
Telegram
Nuvation Bio Shares | NUVB
Annual Shares Nuvation Bio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 342 M | 269 M | 219 M | 217 M | 198 K | - | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 342 M | 198 K | 209 M |
Quarterly Shares Nuvation Bio
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 349 M | 347 M | 342 K | 341 K | 339 K | 338 M | 274 K | 245 K | 219 K | 219 M | 219 K | 219 K | 219 K | 219 M | 218 K | 217 K | 213 K | 218 M | 207 K | 204 K | 170 K | 149 M | 91.8 K | 88.7 K | 85.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 349 M | 88.7 K | 77.1 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ARCA biopharma
ABIO
|
48.7 M | - | 1052.0 % | $ 415 M |  USA |
 |
Acasti Pharma
ACST
|
16.5 M | - | 4.01 % | $ 150 M |  Canada |
 |
ADiTx Therapeutics
ADTX
|
37.4 K | - | - | $ 374 | USA |
 |
Aeterna Zentaris
AEZS
|
3.17 M | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
10.2 M | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
14.3 M | - | 1.93 % | $ 17.4 M | USA |
 |
Aileron Therapeutics
ALRN
|
25.4 M | - | 10.36 % | $ 9.8 M | USA |
 |
AlloVir
ALVR
|
15.3 M | - | 4.14 % | $ 49.1 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
126 M | - | - | $ 5.18 B | USA |
 |
Athira Pharma
ATHA
|
4.28 M | - | - | $ 269 M | USA |
 |
Avenue Therapeutics
ATXI
|
3.13 M | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
18.3 M | - | 1083.1 % | $ 745 M | USA |
 |
AstraZeneca PLC
AZN
|
1.55 B | - | - | $ 96.9 B |  Britain |
 |
Brainstorm Cell Therapeutics
BCLI
|
9.27 M | - | -2.5 % | $ 5.88 M | USA |
 |
BeiGene, Ltd.
BGNE
|
1.42 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bio-Path Holdings
BPTH
|
2.4 M | - | - | $ 100 K | USA |
 |
Cara Therapeutics
CARA
|
7.42 M | - | -3.03 % | $ 260 M | USA |
 |
ChromaDex Corporation
CDXC
|
79.2 M | - | -0.88 % | $ 598 M | USA |
 |
Caladrius Biosciences
CLBS
|
8.69 M | - | -16.75 % | $ 25.8 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
2.19 M | - | -5.98 % | $ 34.1 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
2.19 M | - | -4.36 % | $ 27 M | USA |
 |
Diffusion Pharmaceuticals
DFFN
|
9.04 M | - | 11.68 % | $ 8.97 M | USA |
 |
Eloxx Pharmaceuticals
ELOX
|
4.38 M | - | -5.68 % | $ 8.28 M | USA |
 |
Enochian Biosciences
ENOB
|
3.36 M | - | - | $ 40.5 M | USA |
 |
Esperion Therapeutics
ESPR
|
208 M | - | - | $ 661 M | USA |
 |
Evofem Biosciences
EVFM
|
124 M | - | 7.55 % | $ 38.1 M | USA |
 |
Eyenovia
EYEN
|
5 M | - | 49.81 % | $ 13.2 M | USA |
 |
FibroGen
FGEN
|
4.04 M | - | - | $ 889 M | USA |
 |
Homology Medicines
FIXX
|
12.3 M | - | 0.77 % | $ 53.4 M | USA |
 |
Amicus Therapeutics
FOLD
|
308 M | - | - | $ 4.47 B | USA |
|
Frequency Therapeutics
FREQ
|
9.4 M | - | - | $ 528 M | USA |
|
Galecto
GLTO
|
1.36 M | - | - | $ 762 M |  Danmark |
 |
GlycoMimetics
GLYC
|
27.6 M | - | 9357.83 % | $ 1.01 B | USA |
 |
Graybug Vision
GRAY
|
15 M | - | -11.23 % | $ 9.65 M | USA |
|
Galera Therapeutics
GRTX
|
98.5 M | - | -32.59 % | $ 7.61 M | USA |
 |
Happiness Biotech Group Limited
HAPP
|
4.73 M | - | 1.35 % | $ 17.8 M |  China |
 |
Hepion Pharmaceuticals
HEPA
|
9.41 M | - | -18.79 % | $ 39.3 K | USA |
 |
Hoth Therapeutics
HOTH
|
13.8 M | - | - | $ 18.8 M | USA |
 |
IMARA
IMRA
|
56.7 M | - | 15.96 % | $ 663 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
53.9 M | - | - | $ 1.45 B | Britain |
 |
KemPharm
KMPH
|
55.3 M | - | -0.34 % | $ 200 M | USA |
 |
Kezar Life Sciences
KZR
|
7.32 M | - | - | $ 53.3 M | USA |
 |
Lixte Biotechnology Holdings
LIXT
|
8.79 M | - | - | $ 63.4 M | USA |
 |
Magenta Therapeutics
MGTA
|
38.6 M | - | -7.74 % | $ 41.6 M | USA |
 |
NovaBay Pharmaceuticals
NBY
|
5.82 M | - | - | $ 11.3 M | USA |
 |
NeuroBo Pharmaceuticals
NRBO
|
1.77 M | - | 0.43 % | $ 12 M | USA |
 |
OncoCyte Corporation
OCX
|
30.5 M | - | 17.22 % | $ 355 K | USA |
 |
Onconova Therapeutics
ONTX
|
8.23 M | - | -0.47 % | $ 21 M | USA |
 |
Opthea Limited
OPT
|
1.22 B | - | - | $ 1.2 B |  Australia |